blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1819674

EP1819674 - FUSED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.08.2012
Database last updated on 15.06.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[N/P]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
Former [2012/32]For all designated states
Schering Corporation
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Former [2010/10]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
Former [2007/34]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Inventor(s)01 / EDMONDSON, Scott, D.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
02 / MASTRACCHIO, Anthony
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
03 / COX, Jason, M.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
 [2007/34]
Representative(s)Buchan, Gavin MacNicol, et al
Merck Sharp & Dohme Limited
European Patent Department
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
[N/P]
Former [2007/34]Buchan, Gavin MacNicol, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Application number, filing date05849849.422.11.2005
[2007/34]
WO2005US42429
Priority number, dateUS20040631517P29.11.2004         Original published format: US 631517 P
[2007/34]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006058064
Date:01.06.2006
Language:EN
[2006/22]
Type: A2 Application without search report 
No.:EP1819674
Date:22.08.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 01.06.2006 takes the place of the publication of the European patent application.
[2007/34]
Type: B1 Patent specification 
No.:EP1819674
Date:05.10.2011
Language:EN
[2011/40]
Search report(s)International search report - published on:US05.10.2006
(Supplementary) European search report - dispatched on:EP16.03.2009
ClassificationIPC:C07D471/04
[2009/16]
CPC:
C07D471/14 (EP); A61P25/22 (EP); A61P25/28 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P43/00 (EP); A61P9/00 (EP); C07D471/04 (EP) (-)
Former IPC [2007/34]C07D211/06
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/34]
TitleGerman:KONDENSIERTE AMINOPIPERIDINE ALS DIPEPTIDYLPEPTIDASE-IV-INHIBITOREN ZUR BEHANDLUNG ODER PRÄVENTION VON DIABETES[2007/34]
English:FUSED AMINOPIPERIDINES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES[2007/34]
French:AMINOPIPERIDINES FUSIONNEES UTILISEES COMME INHIBITEURS DE LA DIPEPTIDYLE PEPTIDASE-IV PERMETTANT DE TRAITER OU DE PREVENIR LE DIABETE[2007/34]
Entry into regional phase29.06.2007National basic fee paid 
29.06.2007Search fee paid 
29.06.2007Designation fee(s) paid 
29.06.2007Examination fee paid 
Examination procedure29.06.2007Examination requested  [2007/34]
14.05.2009Despatch of a communication from the examining division (Time limit: M06)
17.11.2009Reply to a communication from the examining division
26.04.2011Communication of intention to grant the patent
23.08.2011Fee for grant paid
23.08.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.05.2009
Opposition(s)06.07.2012No opposition filed within time limit [2012/37]
Fees paidRenewal fee
06.11.2007Renewal fee patent year 03
27.03.2008Renewal fee patent year 04
06.11.2009Renewal fee patent year 05
22.10.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
FI05.10.2011
HU05.10.2011
IT05.10.2011
LT05.10.2011
LV05.10.2011
PL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
TR05.10.2011
IE22.11.2011
LU22.11.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
IS05.02.2012
PT06.02.2012
[2013/45]
Former [2013/44]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
FI05.10.2011
IT05.10.2011
LT05.10.2011
LV05.10.2011
PL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
TR05.10.2011
IE22.11.2011
LU22.11.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
IS05.02.2012
PT06.02.2012
Former [2013/29]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
FI05.10.2011
IT05.10.2011
LT05.10.2011
LV05.10.2011
PL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
IE22.11.2011
LU22.11.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
IS05.02.2012
PT06.02.2012
Former [2013/25]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
IT05.10.2011
LT05.10.2011
LV05.10.2011
PL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
IE22.11.2011
LU22.11.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
IS05.02.2012
PT06.02.2012
Former [2013/22]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
IT05.10.2011
LT05.10.2011
LV05.10.2011
PL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
IE22.11.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
ES16.01.2012
IS05.02.2012
PT06.02.2012
Former [2013/07]AT05.10.2011
BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
IT05.10.2011
LT05.10.2011
LV05.10.2011
PL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
IE22.11.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/47]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
IT05.10.2011
LT05.10.2011
LV05.10.2011
PL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
IE22.11.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/37]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
IT05.10.2011
LT05.10.2011
LV05.10.2011
PL05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/36]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
LT05.10.2011
LV05.10.2011
RO05.10.2011
SE05.10.2011
SI05.10.2011
SK05.10.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/35]BE05.10.2011
CY05.10.2011
CZ05.10.2011
DK05.10.2011
EE05.10.2011
LT05.10.2011
LV05.10.2011
SE05.10.2011
SI05.10.2011
MC30.11.2011
BG05.01.2012
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/34]BE05.10.2011
CY05.10.2011
CZ05.10.2011
LT05.10.2011
LV05.10.2011
SE05.10.2011
SI05.10.2011
MC30.11.2011
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/29]BE05.10.2011
CY05.10.2011
LT05.10.2011
LV05.10.2011
SE05.10.2011
SI05.10.2011
MC30.11.2011
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/28]BE05.10.2011
CY05.10.2011
LT05.10.2011
LV05.10.2011
SE05.10.2011
SI05.10.2011
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/24]BE05.10.2011
LT05.10.2011
LV05.10.2011
SE05.10.2011
SI05.10.2011
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/23]BE05.10.2011
LT05.10.2011
SI05.10.2011
GR06.01.2012
IS05.02.2012
PT06.02.2012
Former [2012/21]BE05.10.2011
LT05.10.2011
SI05.10.2011
IS05.02.2012
Former [2012/20]LT05.10.2011
SI05.10.2011
Former [2012/11]SI05.10.2011
Documents cited:Search[A]EP1338595  (EISAI CO LTD [JP]) [A] 1-13* the whole document *;
 [E]WO2007024993  (MERCK & CO INC [US], et al) [E] 1-13 * the examples, claims 11-14 *
International search[A]GB496258  (GILBERT THOMAS MORGAN, et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.